Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL

A. Campanella, A. Capasso, S. Heltai, C. Taccetti, E. Albi, Y. Herishanu, S. Haggenburg, T. Chatzikonstantinou, M. Doubek, M. Kättström, K. Giannopoulos, M. Simkovic, C. Moreno, M. Massaia, H. Bumbea, S. Alshemmari, P. Ranghetti, E. Perotta, F. Martini, E. Sant'AntonioM. Colia, C. Combi, S. Levi, A. P. Kater, M. Hazenberg, I. S. Nijhof, Q. Hofsink, C. Demosthenous, J. Kotaskova, J. Zaleska, F. Vrbacky, A. Mora Raya, D. Bisogno, I. E. Tripoli, V. M. Popov, V. Roman, N. Stavroyianni, M. Karypidou, E. Scarano, M. Locatelli, M. Frenquelli, L. Scarfò, K. Stamatopoulos, P. Ghia

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)745-750
Number of pages6
JournalAmerican journal of hematology
Issue number4
Early online date2024
Publication statusPublished - Apr 2024

Cite this